| Trial registration number
|
NCT04693026 |
Full text link
Last imported at : Jan. 6, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
https://clinicaltrials.gov/show/NCT04693026
|
First author
Last imported at : Jan. 6, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
Abu Taiub Mohammed Mohiuddin Chowdhury, MBBS, MD
|
Contact
Last imported at : Jan. 6, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
dr_mohiuddinchy@yahoo.com
|
Registration date
Last imported at : Jan. 7, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
2021-01-05
|
Recruitment status
Last imported at : Dec. 4, 2022, 8 p.m.
Source : ClinicalTrials.gov
|
Unknown
|
Study design
Last imported at : Jan. 6, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
RCT
|
Allocation
Last imported at : Jan. 6, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
Randomized
|
Design
Last imported at : Jan. 6, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
Parallel
|
Masking
Last imported at : Jan. 6, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
Open label
|
Center
Last imported at : March 15, 2023, 4 a.m.
Source : ClinicalTrials.gov
|
single-center
|
Study aim
Last imported at : Jan. 6, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
Treatment
|
Inclusion criteria
Last imported at : Jan. 6, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
inclusion criteria:
severe covid-19 patients require hospitalization under hdu/icu. the sarscov-2 infection
will be confirmed by rt pcr / ct chest in every case.
|
Exclusion criteria
Last imported at : Jan. 6, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
participants with uncontrolled clinical status who were hospitalized from the before.
contraindication / possible drug interaction. participants who have any severe and/or
uncontrolled medical conditions like, severe ischemic heart disease, epilepsy, malignancy,
pulmonary/ renal/hepatic disease, aids, pulmonary tb, pregnancy, corpulmonale, and etc.
|
Number of arms
Last imported at : Jan. 6, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
2
|
Funding
Last imported at : Jan. 6, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
M Abdur Rahim Medical College and Hospital
|
Inclusion age min
Last imported at : Jan. 6, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
2
|
Inclusion age max
Last imported at : Jan. 6, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
100
|
Countries
Last imported at : Jan. 6, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
Bangladesh
|
Type of patients
Last imported at : Jan. 6, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
Severe/critical disease at enrollment
|
Severity scale
Last imported at : Jan. 6, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
7: Severe/critical disease at enrollment
|
Total sample size
Last imported at : Jan. 6, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
150
|
primary outcome
Last imported at : Jan. 6, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
Time to Clinical Improvement (TTCI)
|
Notes
Last imported at : Jan. 6, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
None
|
Phase
Last imported at : Feb. 25, 2021, 7:58 p.m.
Source : ClinicalTrials.gov
|
Phase 3
|
Arms
Last imported at : Jan. 6, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
[{"arm_notes": "", "treatment_id": 1680, "treatment_name": "Baricitinib+remdesivir", "treatment_type": "Kinase inhibitors+antivirals", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 1689, "treatment_name": "Remdesivir+tocilizumab", "treatment_type": "Antivirals+interleukin inhibitors", "pharmacological_treatment": "Pharmacological treatment"}]
|